Scilex Holding Company (SCLX) is a Healthcare · Drug Manufacturers - General company listed on NASDAQ. Price $5.04 (-6.15%), Market cap $0.04B, 52-week low–high $4.55 ~ $30.00.
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates,
Financial statements, price targets, institutional (13F) holdings and related news for Scilex Holding Company are updated in real time on BlackAll Trade.
Scilex Holding Company trades at $5.04 (-6.15%). Real-time quotes and charts are available on BlackAll Trade.
Scilex Holding Company has a market cap of about $0.04B.
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (li